Simultaneous turnover studies of thyroxine, 3,5,3' and 3,3',5'-triiodothyronine, 3,5-, 3,3'-, and 3',5'- diiodothyronine, and 3'-monoiodothyronine in chronic renal failure
- PMID: 6401746
- DOI: 10.1210/jcem-56-2-211
Simultaneous turnover studies of thyroxine, 3,5,3' and 3,3',5'-triiodothyronine, 3,5-, 3,3'-, and 3',5'- diiodothyronine, and 3'-monoiodothyronine in chronic renal failure
Abstract
The present study evaluates the sequential extra-thyroidal monodeiodination of thyroid hormones through tri-, di-, and monoiodothyronines in chronic renal failure (CRF) in man. Simultaneous turnover studies of T4, T3, rT3, 3,5-diiodothyronine (3,5-T2), 3,3'-T2, 3',5'-T2, 3'5'-T2, and 3'-monoiodothyronine (3--T1) were conducted in six patients with CRF (creatinine clearance, 9-18 ml/min) using the single-injection, noncompartmental approach. Serum levels of T4, T3, and 3,5-T2 were reduced to two thirds of control levels (P less than 0.05), whereas serum rT3 and 3,3'-T2 levels were reduced to a minor degree. Serum 3'-5'-T1 was doubled (p less than 0.05). The MCRs of T4, rT3, and 3',5'-T2 were enhanced to 168%, 127%, and 187% of normal (P less than 0.05), respectively, whereas those of T3, 3,5-T2, 3,3'-T2, and 3'-T1 were unaffected. The mean production rates (PRs) of the iodothyronines in CRF were as follows (CRF vs. control values, expressed as nanomoles per day/70 kg): T4, 119 vs. 125; T3, 26 vs. 44 (P less than 0.01); rT3, 49 vs, 48; 3,5-T2, 3.5 vs. 7.2 (P less than 0.001); 3,3'-T2, 25 vs. 35 (P less than 0.01); 3',5'-T2, 25 vs. 14 (P less than 0.01); and 3'-T1, 39 vs. 30. Previous studies have demonstrated reduced phenolic ring (5'-) deiodination of T4 in CRF, which is supported by the present finding of unaltered PR of T4 and reduced PR of T3. In contrast the 5'-deiodination of T3 leading to the formation of 3,5-T2 was found unaffected by CRF, since the conversion rate (CR) of T3 to 3,5-T2 (PR 3,5-T2/PR T3) was unaltered (16% vs. 15% in controls). The tyrosylic ring (5-) deiodination of T4 to rT3 was unaffected in patients with CRF, the CR being 42% vs. 40% in controls, in contrast to an enhanced CR of rT3 to 3',5'-T2 (53% vs. 29%, P less than 0.01), which also is a 5-deiodination step. In conclusion, our data show that CRF profoundly changes the kinetics of all iodothyronines studied. Furthermore, our data are compatible with the existence of more than one 5'-deiodinase as well as more than one 5-deiodinase in man.
Similar articles
-
Kinetic studies of thyroxine, 3,5,3'-triiodothyronine, 3,3,5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis.J Clin Endocrinol Metab. 1981 Nov;53(5):978-84. doi: 10.1210/jcem-53-5-978. J Clin Endocrinol Metab. 1981. PMID: 7287881
-
The extrathyroidal effect of D,L-propranolol on 3,3',5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine kinetics.J Clin Endocrinol Metab. 1982 Jun;54(6):1097-100. doi: 10.1210/jcem-54-6-1097. J Clin Endocrinol Metab. 1982. PMID: 7076792
-
The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.J Clin Endocrinol Metab. 1985 Dec;61(6):1093-9. doi: 10.1210/jcem-61-6-1093. J Clin Endocrinol Metab. 1985. PMID: 4055984
-
Radioimmunoassay of thyroxine (T4), 3,5,3'-triiodothyronine (T3), 3,3',5'-triiodothyronine (reverse T3, rT3), and 3,3'-diiodothyronine (T2).Methods Enzymol. 1982;84:272-303. doi: 10.1016/0076-6879(82)84024-x. Methods Enzymol. 1982. PMID: 7048011 Review. No abstract available.
-
Thyroid hormone metabolism in obesity.Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S113-5. doi: 10.1038/sj.ijo.0801293. Int J Obes Relat Metab Disord. 2000. PMID: 10997624 Review.
Cited by
-
Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2?Thyroid. 2015 Feb;25(2):188-97. doi: 10.1089/thy.2014.0262. Epub 2014 Nov 24. Thyroid. 2015. PMID: 25343227 Free PMC article.
-
3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice.Endocrinology. 2015 Jan;156(1):389-99. doi: 10.1210/en.2014-1604. Endocrinology. 2015. PMID: 25322465 Free PMC article.
-
Deiodinases in thyroid tumorigenesis.Endocr Relat Cancer. 2023 Apr 13;30(5):e230015. doi: 10.1530/ERC-23-0015. Print 2023 May 1. Endocr Relat Cancer. 2023. PMID: 36862025 Free PMC article. Review.
-
Urine Metabolomics by (1)H-NMR Spectroscopy Indicates Associations between Serum 3,5-T2 Concentrations and Intermediary Metabolism in Euthyroid Humans.Eur Thyroid J. 2015 Sep;4(Suppl 1):92-100. doi: 10.1159/000381308. Epub 2015 May 28. Eur Thyroid J. 2015. PMID: 26601079 Free PMC article.
-
Hypothalamic-pituitary thyroid abnormalities in children after renal transplantation.Pediatr Nephrol. 1996 Oct;10(5):621-4. doi: 10.1007/s004670050174. Pediatr Nephrol. 1996. PMID: 8897569
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials